------------------------------
OMB APPROVAL
------------------------------
OMB Number 3235-0287
Expires: September 30, 1998
Estimated average burden
hours per response ....... 0.5
------------------------------
U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 4
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or
Section 30(f) of the Investment Company Act of 1940
[X] Check this box if no longer subject to Section 16. Form 4 or Form 5
obligations may continue. See Instruction 1(b).
(Print or Type Responses)
________________________________________________________________________________
1. Name and Address of Reporting Person*
Ion Beam Applications s.a.
- --------------------------------------------------------------------------------
(Last) (First) (Middle)
Chemin du Cyclotron, 3
- --------------------------------------------------------------------------------
(Street)
B-1348 Louvain-la-Neuve, Belgium
- --------------------------------------------------------------------------------
(City) (State) (Zip)
________________________________________________________________________________
2. Issuer Name and Ticker or Trading Symbol
SteriGenics International, Inc. (STER)
________________________________________________________________________________
3. IRS Identification Number of Reporting Person, if an Entity (Voluntary)
________________________________________________________________________________
4. Statement for Month/Year
July, 1999
________________________________________________________________________________
5. If Amendment, Date of Original (Month/Year)
________________________________________________________________________________
6. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
[_] Director [X] 10% Owner
[_] Officer (give title below) [_] Other (specify below)
________________________________________________________________________________
7. Individual or Joint/Group Filing (Check applicable line)
[_] Form filed by One Reporting Person
[X] Form filed by More than One Reporting Person
________________________________________________________________________________
================================================================================
Table I -- Non-Derivative Securities Acquired, Disposed of,
or Beneficially Owned
================================================================================
<TABLE>
<CAPTION>
6.
4. 5. Owner-
Securities Acquired (A) or Amount of ship
3. Disposed of (D) Securities Form: 7.
Transaction (Instr. 3, 4 and 5) Beneficially Direct Nature of
2. Code ------------------------------- Owned at End (D) or Indirect
1. Transaction (Instr. 8) (A) of Month Indirect Beneficial
Title of Security Date ------------ Amount or Price (Instr. 3 (I) Ownership
(Instr. 3) (mm/dd/yy) Code V (D) and 4) (Instr.4) (Instr. 4)
- ------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C>
Common Stock 7/16/99 S 751,300 D (1) 0 D
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock and associated
rights to purchase Series A
Junior Participating
Preferred Stock 7/20/99 J(1) 7,241,037 A (1) 7,241,037 I (1)
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
====================================================================================================================================
</TABLE>
Explanation of Responses:
(1) Pursuant to that certain Merger Agreement, dated as of June 10, 1999, among
Ion Beam Applications s.a. (the "Reporting Person"), Ion Beam Applications
G.P. ("IBA GP"), IBA Acquisition Corp. ("Acquisition") and SteriGenics
International, Inc. ("SteriGenics"), following Acquisition's acquisition by
a tender offer, which expired on July 16, 1999, of approximately 98.2% of
the issued and outstanding Common Stock and associated rights to purchase
Series A Junior Participating Preferred Stock (collectively, the "Shares")
for $27.00 per Share, as reported on Acquisition's Form 3 dated July 28,
1999, Acquisition was merged with and into SteriGenics as of July 20, 1999,
and Acquisition ceased to exist as a separate corporate entity.
Following the merger of Acquisition with and into SteriGenics, in
accordance with the General Corporation Law of Delaware, all of the issued
and outstanding Shares of SteriGenics are held by IBA GP, the sole
stockholder of SteriGenics and a Delaware general partnership, of which the
Reporting Person is the General Partner.
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
* If the Form is filed by more than one Reporting Person, see Instruction
4(b)(v).
Potential Persons who are to respond to the collection of information contained
in this form are not required to respond unless the form displays a currently
valid OMB control number.
Page 1 of 3
(Over)
SEC 1474 (7-97)
<PAGE>
FORM 4 (continued)
Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
================================================================================
<TABLE>
<CAPTION>
10.
9. Owner-
Number ship
of Form
2. Deriv- of
Conver- 5. 7. ative Deriv- 11.
sion Number of Title and Amount Secur- ative Nature
or Derivative 6. of Underlying 8. ities Secur- of
Exer- 4. Securities Date Securities Price Bene- ity: In-
cise 3. Trans- Acquired (A) Exercisable and (Instr. 3 and 4) of ficially Direct direct
Price Trans- action or Disposed Expiration Date ---------------- Deriv- Owned (D) or Bene-
1. of action Code of(D) (Month/Day/Year) Amount ative at End In- ficial
Title of Deriv- Date (Instr. (Instr. 3, ---------------- or Secur- of direct Owner-
Derivative ative (Month/ 8) 4 and 5) Date Expira- Number ity Month (I) ship
Security Secur- Day/ ------ ------------ Exer- tion of (Instr. (Instr. (Instr. (Instr.
(Instr. 3) ity Year) Code V (A) (D) cisable Date Title Shares 5) 4) 4) 4)
- ------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C>
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------
====================================================================================================================================
</TABLE>
ION BEAM APPLICATIONS S.A.
By: /s/ Pierre Mottet August 9, 1999
------------------------------------------ -----------------------
**Signature of Reporting Person Date
Pierre Mottet,
Chief Executive Officer
** Intentional misstatements or omissions of facts constitute Federal
Criminal Violations.
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed.
If space is insufficient, see Instruction 6 for procedure.
Potential persons who are to respond to the collection of information contained
in this form are not required to respond unless the form displays a currently
valid OMB Number.
Page 2 of 3
SEC 1474 (7-97)
<PAGE>
Joint Filer Information
Name: Ion Beam Applications G.P.
Address: Chemin du Cyclotron, 3
B-1348 Louvain-la-Neuve, Belgium
Designated Filer: Ion Beam Applications s.a.
Issuer and
Ticker Symbol: SteriGenics International, Inc. (STER)
Statement for
Month/Year: July, 1999
Signature: ION BEAM APPLICATIONS G.P.
By: ION BEAM APPLICATIONS s.a.,
Its General Partner
By: /s/ Pierre Mottet
--------------------------------------
Pierre Mottet, Chief Executive Officer
Page 3 of 3
